Back to search
FDAFDA · Food and drugs·Recall number D-0529-2022

APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00

Published February 16, 2022 · Recall initiated: January 26, 2022

Summary

FDA records drug Class II recall D-0529-2022, published February 16, 2022 and initiated January 26, 2022. Recalling firm: ULTRAtab Laboratories, Inc.; Status: Terminated; Reported quantity: 451,123 tablets; Lot: Product Codes: C135LA Bulk Lots: 19F077. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ULTRAtab Laboratories, Inc.
Distributor
Bulk product was distributed to 3 distributors who may have distributed finished product.
Lot
Product Codes: C135LA Bulk Lots: 19F077
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00 recalled?

Yes. FDA published recall D-0529-2022 on February 16, 2022. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter